Ibrutinib: Another Weapon in Our Arsenal Against Lympho-Proliferative Disorders

Expert Opinion on Pharmacotherapy - United Kingdom
doi 10.1517/14656566.2015.1109634
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa Healthcare

Related search

The Reoriented Neoplasm: Post-Transplant Lympho- Proliferative Disorders

Archives in Biomedical Engineering & Biotechnology
2018English

Our Most Powerful Weapon to Fight COVID-19: Patient Involvement

Patient
Nursing
2020English

New Evidence on Carbetocin: Another Arrow in Our Quiver

Global health, science and practice
Health PolicyPublic HealthOccupational HealthEnvironmental
2018English

New Weapon Promising Against Deadly P. Aeruginosa Strain

Microbe
Microbiology
2010English

Ibrutinib Induces Multiple Functional Defects in the Neutrophil Response Against Aspergillus Fumigatus

Haematologica
Hematology
2019English

Radio-Immunotherapy: A Promising Weapon to Consider in the Fight Against NSCLC

International Journal of Radiology & Radiation Therapy
2017English

Sigma 1 Receptor Modulators as a New Weapon Against Multiple Sclerosis

BioDiscovery
2017English

Therapeutic Interventions Against Inflammatory and Angiogenic Mediators in Proliferative Diabetic Retinopathy

Mediators of Inflammation
ImmunologyCell Biology
2012English

Our Defence Against Small-Pox.

The Lancet
Medicine
1925English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy